ClinicalTrials.Veeva
Menu

Find clinical trials for Heart Disease in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Cardiovascular Diseases
Heart Failure
Coronary Artery Disease
Myocardial Ischemia
Aortic Valve Stenosis
Mitral Valve Insufficiency

Heart Disease trials near Barcelona, CT, ESP:

Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System (VIVA)

This is a prospective, single arm, multicenter study in an cohort of up to 267 patients (up to 100 Roll-ins and 167 patients implanted per protocol)...

Enrolling
Symptomatic Aortic Stenosis
Device: Vienna Aortic Valve SE System
P+F Products + Features

Barcelona, Barcelona, Spain and 31 other locations

Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation (VANTAGE)

Evaluation of TAVR using the NAVITOR valve in a Global Investigation.

Active, not recruiting
Symptomatic Severe Aortic Stenosis
Device: Navitor Transcatheter Aortic valve and FlexNav Delivery system
Abbott
Abbott

Barcelona, Spain and 36 other locations

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions (BIOMAG-LL)

The study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm le...

Enrolling
Ischemic Heart Disease
Coronary Artery Disease
Device: Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold
Biotronik

Barcelona, Spain and 7 other locations

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial

tomography (OCT) findings indicative of vulnerable plaque, in patients with ST-elevation myocardial infarction (STEMI) and multivessel disease...

Enrolling
Ischemic Heart Disease
Coronary Artery Disease
Other: FFR>0.80+ OCT with findings indicative of vulnerable plaque
Fundación EPIC

Barcelona, Spain and 48 other locations

A Clinical Study of X-Clip Mitral Valve Clip System and Steerable Guide System for Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation

Shenzhen Lifevalve Medical Scientific Co., Ltd. has developed a new X-Clip Mitral Valve Clip System and its compatible Steerable Guide System, aiming...

Begins enrollment in 8 months
Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation
Device: X-Clip Treatment for Degenerative Mitral Regurgitation
Shenzhen Lifevalve Medical Scientific Co., Ltd.

Barcelona, Spain and 2 other locations

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk (ACCLAIM-CTA)

in your blood. People with high Lp(a) have a higher risk for heart disease. The main purpose of the study is to investigate how lep...

Enrolling
Cardiovascular Diseases
Lipoprotein(a)
Drug: Lepodisiran
Drug: Placebo

Phase 3

Lilly
Lilly

Barcelona, Spain and 58 other locations

Transition to KPL-387 Monotherapy Dosing & Administration Study

The primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapie...

Enrolling
Heart Diseases
Pericarditis
Drug: KPL-387

Phase 2

Kiniksa Pharmaceuticals International, plc

Barcelona, Spain and 32 other locations

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart f...

Enrolling
Heart Valve Diseases
Cardiovascular Diseases
Other: Guideline Directed Heart Failure Medication
Device: Carillon Mitral Contour System
Cardiac Dimensions

Barcelona, Spain and 92 other locations

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a stic...

Enrolling
Heart Diseases
Transthyretin Amyloidosis
Drug: Placebo oral tablet
Drug: Acoramidis

Phase 3

Eidos Therapeutics

Barcelona, Spain and 100 other locations

Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients (TripleTRE)

TripleTRE investigates the effect of initial triple combination therapy (oral endothelin receptor antagonist (ERA) + oral phosphodiesterase tyüe-5 in...

Enrolling
Pulmonary Arterial Hypertension
Drug: Generic treprostinil sodium + Standard of Care (Double Oral)
Drug: Standard of Care - Double Oral

Phase 4

AOP Orphan

Barcelona, Spain and 18 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2026 Veeva Systems